UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 157

Sortiert nach

A Retrospective Analysis of R-MPV Plus Response-adapted Whole-brain Radiotherapy for Elderly Patients with Primary Central Nervous System Lymphoma

Internal Medicine, 2022/05/01, Vol.61(9), pp.1345-1352

2022

Link zum Volltext

Verfügbarkeit prüfen

Once-weekly vs. twice-weekly carfilzomib dosing in a subgroup of Japanese relapsed and refractory multiple myeloma patients from a randomized phase 3 trial (A.R.R.O.W.) and comparison with ENDEAVOR

International journal of hematology, 2021-02, Vol.113 (2), p.219-230

2021

Link zum Volltext

Verfügbarkeit prüfen

High Complete Remission Rate and Promising Outcome by Combination of Imatinib and Chemotherapy for Newly Diagnosed BCR-ABL–Positive Acute Lymphoblastic Leukemia: A Phase II Study by the Japan Adult Leukemia Study Group

Journal of clinical oncology, 2006-01, Vol.24 (3), p.460-466

2006

Link zum Volltext

Verfügbarkeit prüfen

Clinical efficacy of fecal occult blood test and colonoscopy for dasatinib-induced hemorrhagic colitis in CML patients

Blood, 2017-01, Vol.129 (1), p.126-128

2017

Link zum Volltext

Verfügbarkeit prüfen

Final analysis of the JALSG Ph+ALL202 study: tyrosine kinase inhibitor-combined chemotherapy for Ph+ALL

Annals of hematology, 2018-09, Vol.97 (9), p.1535-1545

2018

Link zum Volltext

Verfügbarkeit prüfen

Combination of clofarabine, etoposide, and cyclophosphamide in adult relapsed/refractory acute lymphoblastic leukemia: a phase 1/2 dose-escalation study by the Japan Adult Leukemia Study Group

International journal of hematology, 2021-03, Vol.113 (3), p.395-403

2021

Link zum Volltext

Verfügbarkeit prüfen

Pomalidomide, dexamethasone, and daratumumab in Japanese patients with relapsed or refractory multiple myeloma after lenalidomide-based treatment

International journal of hematology, 2022-07, Vol.116 (1), p.122-130

2022

Link zum Volltext

Verfügbarkeit prüfen

Carfilzomib, lenalidomide and dexamethasone in patients with heavily pretreated multiple myeloma: A phase 1 study in Japan

Cancer science, 2017-03, Vol.108 (3), p.461-468

2017

Link zum Volltext

Verfügbarkeit prüfen

Diffuse large B cell lymphoma primarily presenting as acute liver failure in a surviving patient

Journal of community hospital internal medicine perspectives, 2019-03, Vol.9 (2), p.135-139

2019

Link zum Volltext

Verfügbarkeit prüfen

Impact of Synchronous Multiple Primary Malignant Tumors on Newly Diagnosed Hematological Malignancies

Clinical lymphoma, myeloma and leukemia, 2017-12, Vol.17 (12), p.e79-e85

2017

Link zum Volltext

Verfügbarkeit prüfen

Trough plasma concentration of imatinib reflects BCR–ABL kinase inhibitory activity and clinical response in chronic‐phase chronic myeloid leukemia: A report from the BINGO study

Cancer science, 2010-10, Vol.101 (10), p.2186-2192

2010

Link zum Volltext

Verfügbarkeit prüfen

End-of-Life Care of Acute Myeloid Leukemia Compared with Aggressive lymphoma in Patients Who Are Eligible for Intensive Chemotherapy: An Observational Study in a Japanese Community Hospital

Palliative medicine reports, 2023-03, Vol.4 (1), p.71-78

2023

Link zum Volltext

Verfügbarkeit prüfen

Multi-Lineage BCR-ABL Expression in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Is Associated With Improved Prognosis but No Specific Molecular Features

Frontiers in oncology, 2020-10, Vol.10, p.586567-586567

2020

Link zum Volltext

Verfügbarkeit prüfen

Plerixafor for mobilization and collection of haematopoietic stem cells for autologous transplantation in Japanese patients with non-Hodgkin lymphoma: a randomized phase 2 study

International journal of hematology, 2018-11, Vol.108 (5), p.524-534

2018

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of imatinib‐based chemotherapy for newly diagnosed BCR‐ABL‐positive acute lymphoblastic leukemia

American journal of hematology, 2017-04, Vol.92 (4), p.367-374

2017

Link zum Volltext

Verfügbarkeit prüfen

Final results of a phase I study of carfilzomib, lenalidomide, and dexamethasone for heavily pretreated multiple myeloma

International journal of hematology, 2020, Vol.111 (1), p.57-64

2020

Link zum Volltext

Verfügbarkeit prüfen

Machine learning-aided risk stratification in Philadelphia chromosome-positive acute lymphoblastic leukemia

Biomarker research, 2021-02, Vol.9 (1), p.13-13, Article 13

2021

Link zum Volltext

Verfügbarkeit prüfen

A survey of blood transfusion errors in Aichi Prefecture in Japan: Identifying major lapses threatening the safety of transfusion recipients

Transfusion and apheresis science, 2020-06, Vol.59 (3), p.102735-102735, Article 102735

2020

Link zum Volltext

Verfügbarkeit prüfen

Effective chemomobilization with etoposide and cytarabine (EC regimen) in lymphoma patients: a single-center, retrospective, observational study

Japanese journal of clinical oncology, 2017-09, Vol.47 (9), p.820-825

2017

Link zum Volltext

Verfügbarkeit prüfen

Retrospective analysis of primary gastric diffuse large B cell lymphoma in the rituximab era: a multicenter study of 95 patients in Japan

Annals of hematology, 2012-03, Vol.91 (3), p.383-390

2012

Link zum Volltext

Verfügbarkeit prüfen

Phase I dose-escalation study of cyclophosphamide combined with bortezomib and dexamethasone in Japanese patients with relapsed and/or refractory multiple myeloma

International journal of hematology, 2015-10, Vol.102 (4), p.434-440

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 157

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(114)
Mit Volltextzugriff
(136)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(79)
Humans
(70)
Life Sciences & Biomedicine
(68)
Female
(51)
Male
(49)
Hematology
(46)
Middle Aged
(46)
Adult
(39)
Aged
(30)
Oncology
(29)
Biological And Medical Sciences
(26)
Medical Sciences
(24)
Hematologic And Hematopoietic Diseases
(18)
Adolescent
(15)
Japan
(14)
Molecular Sequence Data
(14)
Prognosis
(14)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(13)
Original Article
(13)
Treatment Outcome
(13)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Monitoring of Hepatitis B Virus (HBV) DNA and Risk of HBV Reactivation in B-Cell Lymphoma: A Prospective Observational Study

A Retrospective Analysis of R-MPV Plus Response-adapted Whole-brain Radiotherapy for Elderly Patients with Primary Central Nervous System Lymphoma

Once-weekly vs. twice-weekly carfilzomib dosing in a subgroup of Japanese relapsed and refractory multiple myeloma patients from a randomized phase 3 trial (A.R.R.O.W.) and comparison with ENDEAVOR

High Complete Remission Rate and Promising Outcome by Combination of Imatinib and Chemotherapy for Newly Diagnosed BCR-ABL–Positive Acute Lymphoblastic Leukemia: A Phase II Study by the Japan Adult Leukemia Study Group

Clinical efficacy of fecal occult blood test and colonoscopy for dasatinib-induced hemorrhagic colitis in CML patients

Final analysis of the JALSG Ph+ALL202 study: tyrosine kinase inhibitor-combined chemotherapy for Ph+ALL

Combination of clofarabine, etoposide, and cyclophosphamide in adult relapsed/refractory acute lymphoblastic leukemia: a phase 1/2 dose-escalation study by the Japan Adult Leukemia Study Group

Pomalidomide, dexamethasone, and daratumumab in Japanese patients with relapsed or refractory multiple myeloma after lenalidomide-based treatment

Carfilzomib, lenalidomide and dexamethasone in patients with heavily pretreated multiple myeloma: A phase 1 study in Japan

Diffuse large B cell lymphoma primarily presenting as acute liver failure in a surviving patient

Impact of Synchronous Multiple Primary Malignant Tumors on Newly Diagnosed Hematological Malignancies

Trough plasma concentration of imatinib reflects BCR–ABL kinase inhibitory activity and clinical response in chronic‐phase chronic myeloid leukemia: A report from the BINGO study

Dasatinib-Based Two-Step Induction Prior to Allogeneic Hematopoietic Cell Transplantation for Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of the JALSG Ph+ALL213 Study

End-of-Life Care of Acute Myeloid Leukemia Compared with Aggressive lymphoma in Patients Who Are Eligible for Intensive Chemotherapy: An Observational Study in a Japanese Community Hospital

Multi-Lineage BCR-ABL Expression in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Is Associated With Improved Prognosis but No Specific Molecular Features

Plerixafor for mobilization and collection of haematopoietic stem cells for autologous transplantation in Japanese patients with non-Hodgkin lymphoma: a randomized phase 2 study

Phase II study of imatinib‐based chemotherapy for newly diagnosed BCR‐ABL‐positive acute lymphoblastic leukemia

Final results of a phase I study of carfilzomib, lenalidomide, and dexamethasone for heavily pretreated multiple myeloma

Machine learning-aided risk stratification in Philadelphia chromosome-positive acute lymphoblastic leukemia

A survey of blood transfusion errors in Aichi Prefecture in Japan: Identifying major lapses threatening the safety of transfusion recipients

Effective chemomobilization with etoposide and cytarabine (EC regimen) in lymphoma patients: a single-center, retrospective, observational study

Autologous peripheral blood stem cell transplantation for Philadelphia chromosome‐positive acute lymphoblastic leukemia is safe but poses challenges for long‐term maintenance of molecular remission: Results of the Auto‐Ph17 study

High‐risk Combinations of Additional Chromosomal Abnormalities in Philadelphia Chromosome‐positive Acute Lymphoblastic Leukemia: JALSG Ph+ALL TKI‐SCT Study

Retrospective analysis of primary gastric diffuse large B cell lymphoma in the rituximab era: a multicenter study of 95 patients in Japan

Phase I dose-escalation study of cyclophosphamide combined with bortezomib and dexamethasone in Japanese patients with relapsed and/or refractory multiple myeloma

Suchergebnisse filtern